The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
21st Annual Meeting of ISMPP: A Summarized Report
The 21st Annual Meeting of ISMPP was held from May 12-14, 2025, in Washington, D.C...
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Celebrating World Patient Safety Day 2024: Improving Diagnosis for a Safer Tomorrow
On World Patient Safety Day 2024, we focus on the critical theme of "Improving Diagnosis...
Improving Health Outcomes by Empowering Patients: The Future Is Here
Empowering patients and involving them as key stakeholders in the drug development lifecycle can help...
Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward
Ensuring that your organization embraces DE & I training is important for cultivating a strong...
- 1
- 2